Stay updated with breaking news from Authorized Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First results from any randomized, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6% against disease during a period when Delta was the prevalent strain
/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
GlaxoSmithKline plc and Vir Biotechnology, Inc. today announced they have signed a Joint Procurement Agreement with the European Commission to supply up to 220,000 doses of sotrovimab, an investigational single dose SARS-CoV-2 monoclonal antibody for the treatment of adults and adolescents (aged 12 years and over ...